First choice for refractory OAB: botulinum toxin A or sacral neuromodulation?

Authors

Findlay MacAskill, Arun Sahai

Published Date

Updated November 2023 (first published October 2016)

DOI

https://doi.org/10.18591/BJUIK.0055.v2

Access E-Learning

Cookie preferences

This site makes use of cookies to help improve our understanding of how you use the site. This information does not directly identify you, but because we respect your right to privacy, you can choose not to allow some types of cookies.